Geron
GERN
#7289
Rank
A$0.81 B
Marketcap
A$1.27
Share price
-5.47%
Change (1 day)
-32.75%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -A$55.73 Million

According to Geron's latest financial reports the company's current earnings are A$0.20 Billion. In 2025 the company made an earning of -A$72.27 Million, an increase over its 2024 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$55.73 Million-22.89%
2025 -A$72.27 Million-67.42%
2024 -A$0.23 Billion-11.23%
2023 -A$0.25 Billion30.22%
2022 -A$0.2 Billion20.15%
2021 -A$0.16 Billion50.08%
2020 -A$0.11 Billion4.46%
2019 -A$0.11 Billion130.68%
2018 -A$44.17 Million8.84%
2017 -A$40.58 Million-3.08%
2016 -A$41.87 Million-22080.6%
2015 A$0.19 M-100.38%
2014 -A$50.59 Million-7.14%
2013 -A$54.48 Million
2011 -A$0.13 Billion19.04%
2010 -A$0.11 Billion8.45%
2009 -A$99.84 Million-2.51%
2008 -A$0.11 Billion14.65%
2007 -A$89.32 Million32.68%
2006 -A$67.32 Million25.59%
2005 -A$53.61 Million4.36%
2004 -A$51.37 Million19.73%
2003 -A$42.9 Million-15.46%
2002 -A$50.75 Million1.94%
2001 -A$49.78 Million33.59%
2000 -A$37.26 Million27.53%
1999 -A$29.22 Million63.13%
1998 -A$17.91 Million15.6%
1997 -A$15.5 Million-10.66%
1996 -A$17.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-A$2.78 Billion 5,130.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$2.79 B-5,363.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$98.42 Million 85.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.35 B-769.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$23.49 Million-55.80%๐Ÿ‡บ๐Ÿ‡ธ USA